title: Tofisopam inhibits the pharmacokinetics of CYP3A4 substrate midazolam.
authors.forename: Mária
authors.initials: M
authors.lastname: Tóth
authors.forename: Sándor
authors.initials: S
authors.lastname: Drabant
authors.forename: Bálint
authors.initials: B
authors.lastname: Varga
authors.forename: Gyula
authors.initials: G
authors.lastname: Végso
authors.forename: Anna
authors.initials: A
authors.lastname: Cseh
authors.forename: Imre
authors.initials: I
authors.lastname: Szentpéteri
authors.forename: Imre
authors.initials: I
authors.lastname: Klebovich
mesh_terms: D000759:Adjuvants, Anesthesia / Q000493:pharmacokinetics*; D000928:Antidepressive Agents / Q000494:pharmacology*; D019540:Area Under Curve; D001569:Benzodiazepines / Q000494:pharmacology*; D051544:Cytochrome P-450 CYP3A / Q000187:drug effects* / Q000378:metabolism; D004347:Drug Interactions; D006207:Half-Life; D006801:Humans; D007413:Intestinal Mucosa / Q000378:metabolism; D007422:Intestines / Q000187:drug effects; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D008297:Male; D008874:Midazolam / Q000493:pharmacokinetics*
chemical_list: D000759:Adjuvants, Anesthesia; D000928:Antidepressive Agents; D001569:Benzodiazepines; D051544:Cytochrome P-450 CYP3A; C510163:CYP3A4 protein, human; D008874:Midazolam; C012582:tofisopam